Channel Medsystems
2 known investors
Channel Medsystems (Cerene) develops easy-to-use medical devices for women's health, aimed at women and their gynecologists. The company operates in the gynecological medical device and femtech category.
Investors · 2
Also in the syndicate · 1
InnovaHealth Partners, LPlead
Funding
SEC filings, press & company announcements- Undisclosed amountSeries CAug 2026
InnovaHealth Partners, LP (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 2
by search overlap
Rf Surgical6 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Minerva Surgical5 shared keywordsMinerva Surgical is a women's health medical device company focused on technologies for conditions such as heavy menstrual bleeding, offering alternatives to hysterectomy. It provides support to clinical teams using its products.
Companies competing with Channel Medsystems for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Venture Capital & Startup Funding Roundup, August 20, 2026: Aramco Ventures, Bessemer Venture Partners, Google, Y Combinator & More - Tech Startupstechstartups.com · Aug 2026
Channel Medsystems Series C, led by InnovaHealth Partners, LP Reaches $30 Million as the Company Accelerates Commercial Expansion of Cerene® | The Manila Timesmanilatimes.net · Aug 2026Frequently asked questions
- What does Channel Medsystems do?
- Channel Medsystems (Cerene) develops easy-to-use medical devices for women's health, aimed at women and their gynecologists. The company operates in the gynecological medical device and femtech category.
- Who are Channel Medsystems's investors?
- Channel Medsystems's investors include Tullis Health Investors.